SCHEMBL23535680

SCHEMBL23535680

COC(=O)c1ccc2nnc(C)cc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.55
ALOX15 P16050 1/20 0.55
PIK3CA P42336 1/20 0.49
PIK3CB P42338 1/20 0.49
PIK3CG P48736 1/20 0.49
PI4KB Q9UBF8 1/20 0.49
LCK P06239 1/20 0.49
KDM4E B2RXH2 6/20 0.48
HPGD P15428 3/20 0.48
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
RXFP1 Q9HBX9 1/20 0.48
GAA P10253 3/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
MAPT P10636 4/20 0.47
ALDH1A1 P00352 3/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23195646 0.81 TDP1 (0.56) HTTKDM4EHPGDKMT2AMEN1
SCHEMBL30159674 0.79 HTT (0.65) HTTALOX15PIK3CAPIK3CBPIK3CG
SCHEMBL1680653 0.79 HTT (0.65) HTTALOX15PIK3CAPIK3CBPIK3CG
SCHEMBL4540728 0.79 HTT (0.60) HTTALOX15PIK3CAPIK3CBPIK3CG
SCHEMBL10466162 0.77 HTT (0.67) HTTALOX15PIK3CAPIK3CBPIK3CG
SCHEMBL31435495 0.76 HTT (0.61) HTTALOX15PIK3CAPIK3CBPIK3CG
SCHEMBL22095171 0.76 HTT (0.54) HTTALOX15PIK3CAPIK3CBPIK3CG
SCHEMBL13597529 0.76 HTT (0.61) HTTALOX15PIK3CAPIK3CBPIK3CG
SCHEMBL23081015 0.75 HTT (0.56) HTTALOX15PIK3CAPIK3CBPIK3CG
SCHEMBL23756982 0.75 HTT (0.52) HTTALOX15PIK3CAPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115427035-B ENL/AF9 YEATS inhibitors 洛克菲勒大学 2025-04-22 CN disclosed
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY 2023-01-26 US disclosed
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY 2023-01-26 US disclosed
CN-115427035-A ENL/AF9YEATS inhibitors 洛克菲勒大学 2022-12-02 CN disclosed
EP-4076440-A1 INHIBITORS OF ENL/AF9 YEATS The Rockefeller University (US) 2022-10-26 EP disclosed
WO-2021127166-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY (US) 2021-06-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS MLLT3, YEATS2, MLLT1 HTT 2490/4885ALOX15 976/4885PIK3CA 3409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.